DFX Intelligence

Data Factory

Private equityFirmventure with pe activity · probablelower middle market

Longview Innovation Corp.

Private Equity

Wilmington, DE

Longview Innovation is cultivating a new era of innovation with groundbreaking science that will challenge the status quo and transform the future.

This is the graph view. The full profile, with its team, deals and sources, is on Private Equity.Open the full profile →

Search this name across graphsid dfx:pe:89d6d510-037e-48e3-a44f-a61b8d6a8897

Data as of Sep 17, 2026 (this record's last observation) from federal regulator filings, firm and issuer disclosures. Page built Sep 21, 2026, 5:03 PM UTC and rebuilt at most every 15 minutes.

Relationships: 45
Dated events: 16
On other graphs: 2
Observed: Sep 13, 2026 to Sep 17, 2026
24 observations

Across DFX

same identity by shared identifier, citation, or a bridge measured by hand

Venture Capitalidentity

Longview Innovation Corp.

Venture manager · shared crd

RIA / Wealth Managementidentity

LONGVIEW INNOVATION CORP.

Registered adviser · shared crd

Facts

fact = as filed or announced; derived = computed by DFX; estimate = a band, never a point

Funds: 2
PE funds: 1
Vintages: 2021 to 2021
PE GAV, 2024 filing: $1.1Mgross asset value on Form ADV; never dry powder
Regulatory AUM: $125M
Investments: 19
Active investments: 11
Size band: LOWER MIDDLE MARKETderivedproxy: $0.00bn Private Equity Fund GAV on the Form ADV filed 2024-10-18
Latest ADV filing: Oct 18, 2024
Employees (ADV): 8
Website: longviewinnovation.com

Funds

Fund	Vintage	Lifecycle	ADV type	Form D sold	GAV	LPs
CT Spv Investment LP	2021	Unknown	Private Equity Fund	n/a	$1.1M	0
IPG Cayman LP	n/a	Harvest	Venture Capital Fund	n/a	$116M	0

Investments

Company	State	Role	Control	Invested	Exited	Status
Optimeos Life Sciences, Inc.	Nj	unknown	unknown	n/a	n/a	active
Carisma Therapeautics	n/a	unknown	unknown	n/a	n/a	active
Lumiode Light Engines	n/a	unknown	unknown	n/a	n/a	active
Taktos Therapeutics	n/a	unknown	unknown	n/a	n/a	active
Tunoptix	n/a	unknown	unknown	n/a	n/a	active
Exyn Technologies	n/a	unknown	unknown	n/a	n/a	active
Mobilion Systems	n/a	unknown	unknown	n/a	n/a	active
Carisma Therapeutics (Exited)	n/a	unknown	unknown	n/a	n/a	unknown
Lumiode Light Engines (Exited)	n/a	unknown	unknown	n/a	n/a	unknown
Cyrus Biotechnology	n/a	unknown	unknown	n/a	n/a	unknown
Abmeta Therapeutics	n/a	unknown	unknown	n/a	n/a	unknown
Email Us → Hello@LongviewInnovation.com	n/a	unknown	unknown	n/a	n/a	unknown
Call Us → 302-526-1610	n/a	unknown	unknown	n/a	n/a	unknown
New York	n/a	unknown	unknown	n/a	n/a	unknown
Connect With Us → LinkedIn	n/a	unknown	unknown	n/a	n/a	unknown
EnaChip Inc.	De	unknown	unknown	n/a	n/a	active
Aptatek Biosciences	n/a	unknown	unknown	n/a	n/a	active
Abmeta Therapeutics Antibodies to novel targets in cancer metastasis.	n/a	unknown	unknown	n/a	n/a	active
Good Giant	n/a	unknown	unknown	n/a	n/a	active

Relationships

Invested in (19)

→ Aptatek BiosciencesCompanyunknown
factDFX's own graph, The subject's own site
→ TunoptixCompanyunknown
factDFX's own graph, The subject's own site
→ Lumiode Light EnginesCompanyunknown
factDFX's own graph
→ EnaChip Inc.Companyunknown
factDFX's own graph, The subject's own site
→ Optimeos Life Sciences, Inc.Companyunknown
factDFX's own graph, The subject's own site
→ Abmeta Therapeutics Antibodies to novel targets in cancer metastasis.Companyunknown
factDFX's own graph
→ Mobilion SystemsCompanyunknown
factDFX's own graph, The subject's own site
→ Exyn TechnologiesCompanyunknown
factDFX's own graph, The subject's own site
→ Good GiantCompanyunknown
factDFX's own graph
→ Taktos TherapeuticsCompanyunknown
factDFX's own graph
→ Carisma TherapeauticsCompanyunknown
factDFX's own graph
→ Email Us → Hello@LongviewInnovation.comCompanyunknown
factThe subject's own site
→ Carisma Therapeutics (Exited)Companyunknown
factThe subject's own site
→ Lumiode Light Engines (Exited)Companyunknown
factThe subject's own site
→ Cyrus BiotechnologyCompanyunknown
factThe subject's own site
→ Abmeta TherapeuticsCompanyunknown
factThe subject's own site
→ Call Us → 302-526-1610Companyunknown
factThe subject's own site
→ New YorkCompanyunknown
factThe subject's own site
→ Connect With Us → LinkedInCompanyunknown
factThe subject's own site

Employs (16)

→ Dimitri GalitzinePersonPortfolio Advisor
factThe subject's own site
→ Joseph CarrollPersonPortfolio Advisor
factThe subject's own site
→ David ParkePersonInvestment Partner
factThe subject's own site
→ Katie MessnerPersonDirector, Portfolio Operations
factThe subject's own site
→ Michael Robert BurychkaPersonOwner
Nov 1, 2021 to presentfactForm ADV, The subject's own site
→ Will MeldrumPersonInvestment Partner
factThe subject's own site
→ Jason SmithPersonManaging Director
factThe subject's own site
→ Brandon J FleischmanPersonChief Legal Officer
Jan 1, 2019 to presentfactForm ADV
→ Mark Vivian Houghton-BerryPersonDirector
Sep 1, 2024 to presentfactForm ADV
→ Gregory Simon SmithPersonDirector
Nov 1, 2021 to presentfactForm ADV
→ Maxwell Robert BakerPersonChief Compliance Officer
Aug 1, 2021 to presentfactForm ADV
→ Craig J SchortzmannPersonDirector
Apr 1, 2019 to presentfactForm ADV
→ David Graham BaynesPersonDirector
Dec 1, 2016 to presentfactForm ADV
→ Emily Tamara JanveyPersonDirector
Jan 1, 2021 to Mar 26, 2024inferenceForm ADV
→ Alan James AubreyPersonDirector
Dec 1, 2016 to Nov 24, 2021inferenceForm ADV
→ Varun ChandraPersonDirector
Feb 1, 2021 to Oct 18, 2024inferenceForm ADV

Manages (2)

→ CT Spv Investment LPFundPrivate Equity Fund
Sep 3, 2021 to presentfactForm ADV
→ IPG Cayman LPFundPrivate Equity Fund
Dec 20, 2018 to presentfactForm ADV

Owns (1)

← Hard Science Investment Management LLCFirmOwner
Nov 1, 2021 to presentfactForm ADV

Dated events

3 bookkeeping events (roster, classification and holdings changes) folded below

Occurred
Oct 18, 2024
Person left
Varun Chandra (Director) no longer on Schedule A of Longview Innovation Corp.
Form ADVobserved 7 days ago
Occurred
Sep 1, 2024
Person joined
Mark Vivian Houghton-Berry joined Schedule A of Longview Innovation Corp. as Director
Form ADVobserved 7 days ago
Occurred
Mar 26, 2024
Person left
Emily Tamara Janvey (Director) no longer on Schedule A of Longview Innovation Corp.
Form ADVobserved 7 days ago
Occurred
Nov 24, 2021
Person left
Alan James Aubrey (Director) no longer on Schedule A of Longview Innovation Corp.
Form ADVobserved 7 days ago
Occurred
Nov 1, 2021
Person joined
Gregory Simon Smith joined Schedule A of Longview Innovation Corp. as Director
Form ADVobserved 7 days ago
Occurred
Aug 1, 2021
Person joined
Maxwell Robert Baker joined Schedule A of Longview Innovation Corp. as Chief Compliance Officer
Form ADVobserved 7 days ago
Occurred
Feb 1, 2021
Person joined
Varun Chandra joined Schedule A of Longview Innovation Corp. as Director
Form ADVobserved 7 days ago
Occurred
Jan 1, 2021
Person joined
Emily Tamara Janvey joined Schedule A of Longview Innovation Corp. as Director
Form ADVobserved 7 days ago
Occurred
Apr 1, 2019
Person joined
Craig J Schortzmann joined Schedule A of Longview Innovation Corp. as Director
Form ADVobserved 7 days ago
Occurred
Jan 1, 2019
Person joined
Brandon J Fleischman joined Schedule A of Longview Innovation Corp. as Chief Compliance Officer
Form ADVobserved 7 days ago
Occurred
Dec 20, 2018
Adviser first adv filing
Longview Innovation Corp. first filed Form ADV in the extract (ERA)
Form ADVobserved 7 days ago
Occurred
Dec 1, 2016
Person joined
Alan James Aubrey joined Schedule A of Longview Innovation Corp. as Director
Form ADVobserved 7 days ago
Occurred
Dec 1, 2016
Person joined
David Graham Baynes joined Schedule A of Longview Innovation Corp. as Director
Form ADVobserved 7 days ago

Show 3 bookkeeping events

Occurred
Sep 1, 2026
Adviser CRD 300077 is not on the SEC registered or exempt adviser roster of 2026-09-01
Occurred
Sep 3, 2021
CT Spv Investment LP first reported on Form ADV by Longview Innovation Corp. (Private Equity Fund), GAV $3,100,000
Occurred
Dec 20, 2018
IPG Cayman LP first reported on Form ADV by Longview Innovation Corp. (Private Equity Fund), GAV $90,300,000

Who to call

the organisation, the role and the published line, with the filing or website that published it; revealed to signed-in accounts

The firm's published line

Revealable: 1 business phone (Form ADV), 1 office address (Form ADV), 1 website (Form ADV), 1 work email (firm website) · as of 2026-09-17

Dimitri Galitzine
Portfolio Advisor · Revealable: 1 professional profile (firm website)
Joseph Carroll
Portfolio Advisor · Revealable: 1 professional profile (firm website)
David Parke
Investment Partner · Revealable: 1 professional profile (firm website)
Katie Messner
Director, Portfolio Operations · Revealable: 1 professional profile (firm website)
Michael Robert Burychka
Owner · Revealable: 1 professional profile (firm website)
Will Meldrum
Investment Partner · Revealable: 1 professional profile (firm website)
Jason Smith
Managing Director · Revealable: 1 professional profile (firm website)

Also named here, with no published line of their own (reach them through the firm): Brandon J Fleischman (Chief Legal Officer), Mark Vivian Houghton-Berry (Director), Gregory Simon Smith (Director), Maxwell Robert Baker (Chief Compliance Officer), Craig J Schortzmann (Director), David Graham Baynes (Director).

Who to call is the organisation, the person's role and the line they published themselves: a business phone, office address, website or profile link from Form ADV, Form 13F or their own website, with that source named on every value. The counts above are what a reveal returns; a personal email is rarely published, so most reveals are the firm's line. Never data bought from a provider, never anything personal. Reveals by plan

Provenance

Graph: Private Equity
Canonical id: dfx:pe:89d6d510-037e-48e3-a44f-a61b8d6a8897
First observed: Sep 13, 2026
Last observed: Sep 17, 2026 4 days ago
Source families: Federal regulator filings, Firm and issuer disclosures
3 registered feeds stand behind this record; each fact above carries its own dates and, where the publisher serves one, its document.
Resolution: Identity across graphs by shared identifier (CRD, CIK, EIN, ADV fund id, individual CRD) or citation; a name match is shown as a candidate and never merged.

Longview Innovation Corp.

Private Equity

Wilmington, DE

Longview Innovation is cultivating a new era of innovation with groundbreaking science that will challenge the status quo and transform the future.

This is the graph view. The full profile, with its team, deals and sources, is on Private Equity.Open the full profile →

Search this name across graphsid dfx:pe:89d6d510-037e-48e3-a44f-a61b8d6a8897

Data as of Sep 17, 2026 (this record's last observation) from federal regulator filings, firm and issuer disclosures. Page built Sep 21, 2026, 5:03 PM UTC and rebuilt at most every 15 minutes.